GoodRx Holdings (GDRX) Receives a Rating Update from a Top Analyst

In a report released yesterday, Aaron Kessler from Raymond James maintained a Hold rating on GoodRx Holdings (GDRXResearch Report). The company’s shares closed last Wednesday at $29.48, close to its 52-week low of $28.84.

According to, Kessler is a top 100 analyst with an average return of 26.8% and a 71.3% success rate. Kessler covers the Technology sector, focusing on stocks such as Jumia Technologies AG, Uber Technologies, and Viant Technology.

GoodRx Holdings has an analyst consensus of Moderate Buy, with a price target consensus of $48.88.

See today’s analyst top recommended stocks >>

GoodRx Holdings’ market cap is currently $11.58B and has a P/E ratio of -28.60. The company has a Price to Book ratio of 30.52.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

GoodRx Holdings Inc provides digital healthcare platform that provides prescription drugs at affordable prices. The company offers services like diabetes testing, general visits, blood tests, HIV testing, Vitamin D screening, Pregnancy testing, and many more.